Your browser doesn't support javascript.
loading
Determinants of Disease Progression in Autosomal Dominant Polycystic Kidney Disease.
Kebede, Molla Asnake; Mengistu, Yewondwosen Tadesse; Loge, Biruk Yacob; Eshetu, Misikr Alemu; Shash, Erkihun Pawlos; Wirtu, Amenu Tolera; Gemechu, Jickssa Mulissa.
Affiliation
  • Kebede MA; Department of Internal Medicine, School of Medicine, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman P.O. Box 260, Ethiopia.
  • Mengistu YT; Department of Nephrology, College of Health Sciences, Addis Ababa University, Addis Ababa P.O. Box 9086, Ethiopia.
  • Loge BY; Durame General Hospital, Internal Medicine Unite, SNNPR, Durame P.O. Box 143, Ethiopia.
  • Eshetu MA; Department of Internal Medicine, School of Medicine, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman P.O. Box 260, Ethiopia.
  • Shash EP; Department of Internal Medicine, School of Medicine, College of Medicine and Health Science, Mizan-Tepi University, Mizan-Aman P.O. Box 260, Ethiopia.
  • Wirtu AT; Meritus Medical Center, Meritus School of Osteopathic Medicine, Hagerstown, MD 21742, USA.
  • Gemechu JM; Department of Foundational Medical Studies, Oakland University William Beaumont School of Medicine, Rochester, MI 48309, USA.
J Pers Med ; 14(9)2024 Sep 02.
Article in En | MEDLINE | ID: mdl-39338190
ABSTRACT

BACKGROUND:

Despite its severity, there has been a lack of adequate study on autosomal dominant polycystic kidney disease (ADPKD) in Ethiopia. This study assessed the clinical profile and determinant factors contributing to renal disease progression.

METHODS:

A retrospective study was conducted on 114 patients for 6 years in Addis Ababa. Patients with ADPKD who had follow-up visits at two health centers were included.

RESULTS:

The mean age at diagnosis was 42.7 ± 12.7 years, with 43% reporting a positive family history of ADPKD. Approximately 22 patients (20%) developed end-stage renal disease, and 12 patients died. The mean estimated glomerular filtration rate at the initial visit was 72.4 mL/min/1.73 m2. The key risk factors associated with disease progression included younger age at diagnosis [adjusted Odds Ratio (aOR) 0.92, 95% CI 0.87-0.98; p = 0.007], male gender (aOR 4.5, 95% CI 1.3-15.95, p = 0.017), higher baseline systolic blood pressure (aOR 1.05, 95% CI 1.01-1.10, p = 0.026), and the presence of comorbidities (aOR 3.95, 95% CI 1.10-14.33, p = 0.037). The progression of renal disease in ADPKD patients significantly correlates with age at diagnosis, gender, presence of comorbidities, and higher baseline systolic blood pressure.

CONCLUSIONS:

These findings underscore the importance of early detection and management of hypertension and comorbidities in ADPKD patients to mitigate disease progression and improve treatment outcomes.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pers Med Year: 2024 Document type: Article Affiliation country: Ethiopia Country of publication: Switzerland

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: J Pers Med Year: 2024 Document type: Article Affiliation country: Ethiopia Country of publication: Switzerland